Log in to save to my catalogue

Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of E...

Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of E...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2897489753

Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study

About this item

Full title

Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study

Publisher

United States: Elsevier Ltd

Journal title

The Lancet infectious diseases, 2024-03, Vol.24 (3), p.266-274

Language

English

Formats

Publication information

Publisher

United States: Elsevier Ltd

More information

Scope and Contents

Contents

The use of specific anti-Ebola virus therapy, especially monoclonal antibodies, has improved survival in patients with Ebola virus disease. We aimed to assess the effect of monoclonal antibodies on anti-Ebola virus antibody responses in survivors of the 2018–20 Ebola outbreak in the Democratic Republic of the Congo.
In this observational prospec...

Alternative Titles

Full title

Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2897489753

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2897489753

Other Identifiers

ISSN

1473-3099

E-ISSN

1474-4457

DOI

10.1016/S1473-3099(23)00552-2

How to access this item